XML 59 R44.htm IDEA: XBRL DOCUMENT v3.25.4
Collaboration and License Agreements - Amgen, Inc. (Details)
Dec. 31, 2025
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Sep. 30, 2016
agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Contract assets $ 9,827,000 $ 0 $ 0  
Contract liabilities included in deferred revenue, current 111,933,000 $ 2,399,000 $ 0  
Amgen Incorporated | Olpasiran Agreement        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Number of agreements | agreement       2
Contract assets 0      
Contract liabilities included in deferred revenue, current 0      
Amgen Incorporated | Olpasiran Agreement | Maximum        
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]        
Additional remaining development regulatory and sales milestones payments $ 485,000,000